If the californian clinic follows the same regimine as for the phase1 trial patient with end stage renal cell carcinoma at Sir Charles Gardiner hospital in 2005,then the cycle will be.
a daily injection for 5 days and a break of 9 days.
After 6 cycles the 17mm tumour shrank by 50%
After 12 cycles the tumour had disappeared.
If this patient responds in a similar way,then I believe SBP is the best risk/reward situation on the market today!
- Forums
- ASX - By Stock
- SBP
- us patient
SBP
solbec pharmaceuticals limited
us patient
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)